134 related articles for article (PubMed ID: 11163644)
1. The anticytomegaloviral activity of raltitrexed is abrogated in quiescent mouse fibroblasts that overexpress thymidylate synthase.
Gribaudo G; Riera L; Lembo D; De Andrea M; Johnson LF; Landolfo S
Virus Res; 2001 Jan; 73(1):57-65. PubMed ID: 11163644
[TBL] [Abstract][Full Text] [Related]
2. Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication.
Gribaudo G; Riera L; Lembo D; De Andrea M; Gariglio M; Rudge TL; Johnson LF; Landolfo S
J Virol; 2000 Jun; 74(11):4979-87. PubMed ID: 10799571
[TBL] [Abstract][Full Text] [Related]
3. The thymidylate synthase inhibitor ZD1694 potently inhibits murine and human cytomegalovirus replication in quiescent fibroblasts.
Lembo D; Gribaudo G; Riera L; Mondo A; Cavallo R; Angeretti A; Landolfo S
Antiviral Res; 2000 Aug; 47(2):111-20. PubMed ID: 10996399
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts.
Gribaudo G; Riera L; Rudge TL; Caposio P; Johnson LF; Landolfo S
J Gen Virol; 2002 Dec; 83(Pt 12):2983-2993. PubMed ID: 12466474
[TBL] [Abstract][Full Text] [Related]
5. Induction of intrachromosomal homologous recombination in human cells by raltitrexed, an inhibitor of thymidylate synthase.
Waldman BC; Wang Y; Kilaru K; Yang Z; Bhasin A; Wyatt MD; Waldman AS
DNA Repair (Amst); 2008 Oct; 7(10):1624-35. PubMed ID: 18603020
[TBL] [Abstract][Full Text] [Related]
6. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
7. Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition.
Welsh SJ; Hobbs S; Aherne GW
Eur J Cancer; 2003 Feb; 39(3):378-87. PubMed ID: 12565992
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cellular dihydrofolate reductase abolishes the anticytomegaloviral activity of methotrexate.
Lembo D; Cavallo R; Cornaglia M; Mondo A; Hertel L; Angeretti A; Landolfo S
Arch Virol; 1999; 144(7):1397-403. PubMed ID: 10481745
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
Chu E; Callender MA; Farrell MP; Schmitz JC
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
[TBL] [Abstract][Full Text] [Related]
10. Involvement of base excision repair in response to therapy targeted at thymidylate synthase.
Li L; Berger SH; Wyatt MD
Mol Cancer Ther; 2004 Jun; 3(6):747-53. PubMed ID: 15210861
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase is essential for efficient HIV-1 replication in macrophages.
Desrosiers V; Barat C; Breton Y; Ouellet M; Tremblay MJ
Virology; 2021 Sep; 561():47-57. PubMed ID: 34146963
[TBL] [Abstract][Full Text] [Related]
12. Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
Herget T; Freitag M; Morbitzer M; Kupfer R; Stamminger T; Marschall M
Antimicrob Agents Chemother; 2004 Nov; 48(11):4154-62. PubMed ID: 15504835
[TBL] [Abstract][Full Text] [Related]
13. Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression.
Pressacco J; Mitrovski B; Erlichman C; Hedley DW
Cancer Res; 1995 Apr; 55(7):1505-8. PubMed ID: 7882359
[TBL] [Abstract][Full Text] [Related]
14. Probing the folate-binding site of human thymidylate synthase by site-directed mutagenesis. Generation of mutants that confer resistance to raltitrexed, Thymitaq, and BW1843U89.
Tong Y; Liu-Chen X; Ercikan-Abali EA; Zhao SC; Banerjee D; Maley F; Bertino JR
J Biol Chem; 1998 Nov; 273(47):31209-14. PubMed ID: 9813027
[TBL] [Abstract][Full Text] [Related]
15. A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and other solid tumours.
Jackman AL; Melin CJ; Kimbell R; Brunton L; Aherne GW; Theti DS; Walton M
Biochim Biophys Acta; 2002 Jul; 1587(2-3):215-23. PubMed ID: 12084463
[TBL] [Abstract][Full Text] [Related]
16. Effect of hammerhead ribozyme against human thymidylate synthase on the cytotoxicity of thymidylate synthase inhibitors.
Kobayashi H; Takemura Y; Miyachi H; Skelton L; Jackman AL
Jpn J Cancer Res; 1995 Nov; 86(11):1014-8. PubMed ID: 8567390
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
[TBL] [Abstract][Full Text] [Related]
18. Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase.
Luo Y; Walla M; Wyatt MD
DNA Repair (Amst); 2008 Feb; 7(2):162-9. PubMed ID: 17942376
[TBL] [Abstract][Full Text] [Related]
19. Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthase.
Ward WH; Kimbell R; Jackman AL
Biochem Pharmacol; 1992 May; 43(9):2029-31. PubMed ID: 1596289
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of Cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents(,).
Bavetsias V; Marriott JH; Melin C; Kimbell R; Matusiak ZS; Boyle FT; Jackman AL
J Med Chem; 2000 May; 43(10):1910-26. PubMed ID: 10821704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
